Pen Injectors to 2026 Devices Therapeutics Markets Forecasts


Pen Injectors to 2026 • PJR333K • October 2026  •  US $3,850 


User-friendly syringe and injection device designs and the availability of an increasing number of drugs in prefilled insertable and disposable cartridges are propelling the growth of pen injection devices for self-administration. The cost of biologicals such as recombinant proteins has created interest in pen injectors to reduce cost and waste associated with the handling of vial-packaged drugs. A second factor is the continued adoption of custom pen designs as a way of differentiating injectables developed for self-administration through product branding. These devices feature one or more user-friendly features to further the product’s desirability relative to competing options.

 

Pen Injectors to 2026

Pen Injectors to 2026

 
 
 
 

 
 
 
 

 

What You Will Learn

• What injectable drugs are supplied in pen injection devices; what are the key market segments, market dynamics and market demographics?
• What are the therapeutic demand drivers and commercial pen products in key product segments?
• What are the design factors, material selection issues, technologies and market development issues?
• How big is the pen injection device market? How fast is it growing? What will it look like in five years?
• Who are the leading device and drug sector participants, their product development activities, business strategies, and corporate alliances and affiliations?
• What is the importance of pharma-device alliances and design partnerships on pen injection device commercialization and market access?
• What is the impact of wirelessly connected pen injection devices on patient care and market growth?
• What are the significant economic, technology, and regulatory factors affecting the market for pen injection devices?

 

Immune Mediated Inflammatory Diseases – Summary of Contents

Executive Summary

Injectable Drug Sector Market Dynamics
The Injectable Drug Ecosystem
Drug Classes and Devices
Indications and Demand
The Pen Injection Device Market
Device Growth Factors
Biological Drugs Proliferating
Growth of Self-Administration
Shifting Demographics
Device Design Innovation
Competitive Landscape
Risk Factors

Pen Injection Device Design Factors
Standardized Pen Platforms
Custom Pen Designs
Reusable Pens/Prefilled Pen Cartridges
Disposable Pens
Variable vs Fixed Dosing
Connected Pens

Important Pen-Delivered Drug Classes
Antibodies
Anticholinergics
Dopamine Receptors
Hematopoietics
Human Growth Hormone
Immune Modulators
Insulins and Antihyperglycemics
Parathyroid Hormone
Reproductive Hormones
Serotonin Antagonists

Pen Injectors – Therapeutic Sector Assessment
Anemia
Inflammatory Autoimmune Diseases
Diabetes
Emergency Medicine
Hepatitis
Hormone Replacement
Osteoporosis
Reproductive Health
Other Commercial Pen Markets & Products

Market Factors
Regulatory Considerations
Patient Preferences and Compliance

Company Profiles